NewStory Group

AI: Hype or Reality? F5's Field CISO, Josh Goldfarb, offers valuable insights in a recent ITtime article. Discover the 7 crucial factors to consider before diving into AI. Click the link to read more. https://lnkd.in/d-fs__np #f5 #security #AI #CISO

The arrival of bots and scams in executive boardrooms: Josh Goldfarb, Global Solutions Architect at F5, explains to security and risk managers in an article published in Calcalist how to speak the language of the board in order to translate security risks into financial risks for the organization. https://lnkd.in/e2q23wNp #F5 #security #risk #finance

API is a powerful technology that enables businesses to innovate faster and keep up with the demanding pace of the market. But they also come with their own set of challenges. They expand the attack surface and expose new entry points to disrupt services and gain access to data, including personally identifiable information (PII). Given the complexity of properly securing APIs, many businesses choose to work with a trusted partner. This approach has advantages, but it is important that businesses understand how to differentiate between a large number of API security offerings. To help you Josh Goldfarb, F5's Global Solutions Architect, shared 10 must-have features that all API security providers should offer. For Josh Goldfarb's full article published in Israel Defense, you can enter the link https://lnkd.in/dmvPAz6n #F5 #API #security #cyber

A decade ago, they worked on a military project that tackled a complex problem. Now, their solution has found its way into consumer wearables, with applications in Garmin bracelets and upcoming integration with Sony headphones. Ruthi Levy writes in MarkerWeek about NeuroBrave, our client - the company that translates electrical signals into insights about the mental and cognitive state. For the full article, go to the attached link. https://lnkd.in/di93cfD6 #NeuroBrave #AI #Garmin # Sony # TheMarker

A word from F5: signatures can be created quickly in a flash against new threats using artificial intelligence, Using LLM models trained to generate regular expressions, we can create signatures that can be deployed to the edge for real-time detection. #F5 #llm #API # AI https://lnkd.in/dtJMNxNa

For Women's Day: We share an enlightening interview with Kara Sprague, Vice President and Chief Product Officer at F5, about her journey to gender equality. According to her: "The answer to the gender gap in management is to cultivate white hat thinking. Learn it, break it, fix it." #F5 #womensday #genderequality #gendergap https://lnkd.in/dDTk4SK9

At any given time, there is a worldwide shortage of living organs for transplantation. In the US alone, over 200,000 people a year need an organ transplant, of which only about 20% receive it. In most countries of the world, the rate of living organ transplant winners is even lower. Israeli BioTech company Bonus Biogroup has developed a network of artificial blood vessels that can assist in the absorption Transplanted organs are transplanted. You can read about it in the article published in Ice. https://lnkd.in/d8YETn2Z #bonusbiogroup #CellTherapy# Blood Vessels#Engineered Organs#Patents#vascular network

Have you fallen victim to a phishing attack? Maybe it was artificial intelligence that answered you? Ofir Kaploshnik, Director of the engineering solutions department for Spain, Israel, Greece, and Cyprus region at F5, details future trends in the cyber world in an article published in Israel Defense Magazine. https://lnkd.in/d-EfkwMc #AI #fishing #security #cyber #cybersecurity #f5

Sharing an article by Dr. Tomer Bronstein, VP of Innovation and Corporate Development at Bonus Biogroup that was published in Calcalist. The article deals with the opportunities and challenges of the Israeli biotech market. "The year 2024 may bring good news for the Israeli biotech market, after two years of drought. PwC's analysis indicates a gradual opening of a window of opportunity for an IPO on Nasdaq for biotech companies with strong clinical data. This is good news for Israeli companies that have suffered in the past year from the lack of capital raising or low prices in the stock market, due to the influence of the legal reform and the war in Gaza. During 2023, the Tel Aviv biomed index will decrease by approximately 9%, while corresponding indices increased by approximately 3% in the United States and by approximately 6% in Europe." https://lnkd.in/ezcAeVdn #biotech #bonusbiogroup #challenges #opportunities

Sorin Boiangiu, Solution Architect for Southern Europe at F5 reveals the company's predictions for 2024. "2024 Technology Outlook: The Convergence of Security" https://lnkd.in/dg9SqyeT %d7%9e%d7%9c%d7%90%d7%9b%d7%95%d7%aa%d7%99%d7%aa-%d7%aa%d7%97%d7%91%d7%a8- %d7%91%d7%99%d7%9f-%d7%90%d7%91%d7%98%d7%97%d7%aa-%d7%9e%d7%99/ #f5 #AI #security #transparency #predictions